Claudia Schuster
Overview
Explore the profile of Claudia Schuster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
798
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moraleda V, Gomez-Catasus J, Schuster C, Carrascal L
Sci Rep
. 2022 Sep;
12(1):16188.
PMID: 36171410
The estimation of the post-mortem interval is crucial to accurately provide bird collision rates against manmade infrastructures. Standard methodologies recommend initially clearing all carcasses to ensure that subsequent collisions can...
2.
Wermke M, Schuster C, Nolte F, Al-Ali H, Kiewe P, Schonefeldt C, et al.
Br J Haematol
. 2016 Oct;
175(5):917-924.
PMID: 27714772
The mammalian-target of rapamycin (also termed mechanistic target of rapamycin, mTOR) pathway integrates various pro-proliferative and anti-apoptotic stimuli and is involved in regulatory T-cell (TREG) development. As these processes contribute...
3.
Balaian E, Schuster C, Schonefeldt C, Germing U, Haase D, Tuve S, et al.
Ann Hematol
. 2016 Aug;
95(11):1805-10.
PMID: 27510179
Lenalidomide (LEN) leads to erythroid improvement in the majority of patients with myelodysplastic syndrome and isolated deletion of the long arm of chromosome 5 (MDS-del(5q)). This effect is believed to...
4.
Zehentmayr F, Hauser-Kronberger C, Zellinger B, Hlubek F, Schuster C, Bodenhofer U, et al.
Clin Epigenetics
. 2016 Mar;
8:28.
PMID: 26962366
Background: A long-term analysis by the Early Breast Cancer Trialist Group (EBCTG) revealed a strong correlation between local control and cancer-specific mortality. MicroRNAs (miRs), short (20-25 nucleotides) non-coding RNAs, have...
5.
Schuster C, Malinowsky K, Liebmann S, Berg D, Wolff C, Tran K, et al.
Histopathology
. 2012 Mar;
60(6B):E37-50.
PMID: 22393911
Aims: Personalized cancer treatment strategies depend on comprehensive and detailed characterization of individual human malignancies. Clinical pathology, particularly immunohistochemical evaluation of biomarkers in tissues, is considered to be the approved...
6.
Schuster C, Budczies J, Faber C, Kirchner T, Hlubek F
Lab Invest
. 2010 Jul;
91(1):157-65.
PMID: 20661226
Global implementation of molecular diagnostics in modern pathology has been limited by the use of formalin-fixed, paraffin-embedded (FFPE) tissues in current routine diagnostic procedures because of modification and degradation of...
7.
Felder B, Radlwimmer B, Benner A, Mincheva A, Todt G, Beyer K, et al.
Am J Med Genet A
. 2009 Apr;
149A(5):952-9.
PMID: 19365831
We describe a patient with autism and brachymetaphalangy, meeting criteria for 2q37 deletion syndrome (also called Albright Hereditary Osteodystrophy-like syndrome or Brachydactyly-Mental Retardation syndrome, OMIM 600430). Our molecular cytogenetic studies,...
8.
Bechtel S, Rosenfelder H, Duda A, Schmidt C, Ernst U, Wellenreuther R, et al.
BMC Genomics
. 2007 Nov;
8:399.
PMID: 17974005
Background: With the completion of the human genome sequence the functional analysis and characterization of the encoded proteins has become the next urging challenge in the post-genome era. The lack...
9.
Szatmari P, Paterson A, Zwaigenbaum L, Roberts W, Brian J, Liu X, et al.
Nat Genet
. 2007 Feb;
39(3):319-28.
PMID: 17322880
Autism spectrum disorders (ASDs) are common, heritable neurodevelopmental conditions. The genetic architecture of ASDs is complex, requiring large samples to overcome heterogeneity. Here we broaden coverage and sample size relative...
10.
Schwerdt G, Freudinger R, Schuster C, Weber F, Thews O, Gekle M
Toxicol Sci
. 2005 Feb;
85(1):735-42.
PMID: 15716484
Cisplatin is a widely used chemotherapeutic agent. Here we show that cisplatin induces apoptosis in renal collecting duct-derived cells (MDCK-C7 cells, resembling principal cells) in a dose-dependent manner. Additionally, we...